A number of firms have modified their ratings and price targets on shares of ConvaTec Group PLC (LON: CTEC) recently:

  • 10/31/2017 – ConvaTec Group PLC had its “hold” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 250 ($3.30) price target on the stock.
  • 10/18/2017 – ConvaTec Group PLC was upgraded by analysts at Numis Securities Ltd to a “reduce” rating. They now have a GBX 180 ($2.38) price target on the stock.
  • 10/17/2017 – ConvaTec Group PLC had its price target lowered by analysts at Credit Suisse Group from GBX 280 ($3.69) to GBX 225 ($2.97). They now have a “neutral” rating on the stock.
  • 10/17/2017 – ConvaTec Group PLC was downgraded by analysts at Peel Hunt to a “hold” rating. They now have a GBX 250 ($3.30) price target on the stock, down previously from GBX 390 ($5.15).
  • 10/17/2017 – ConvaTec Group PLC was downgraded by analysts at HSBC Holdings plc to a “hold” rating. They now have a GBX 240 ($3.17) price target on the stock, down previously from GBX 345 ($4.55).
  • 10/17/2017 – ConvaTec Group PLC had its price target lowered by analysts at Citigroup Inc. from GBX 290 ($3.83) to GBX 226 ($2.98). They now have a “neutral” rating on the stock.
  • 10/16/2017 – ConvaTec Group PLC was downgraded by analysts at Numis Securities Ltd to a “sell” rating. They now have a GBX 220 ($2.90) price target on the stock.
  • 10/11/2017 – ConvaTec Group PLC had its “neutral” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 290 ($3.83) price target on the stock.
  • 9/20/2017 – ConvaTec Group PLC had its “overweight” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a GBX 303 ($4.00) price target on the stock.
  • 9/11/2017 – ConvaTec Group PLC had its “buy” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a GBX 330 ($4.35) price target on the stock.

In other ConvaTec Group PLC news, insider Christopher Gent bought 38,889 shares of ConvaTec Group PLC stock in a transaction that occurred on Wednesday, October 18th. The shares were bought at an average cost of GBX 213 ($2.81) per share, with a total value of £82,833.57 ($109,307.96). Also, insider Frank Schulkes bought 50,000 shares of ConvaTec Group PLC stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average cost of GBX 196 ($2.59) per share, for a total transaction of £98,000 ($129,321.72).

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.